Drug Pipeline

RMC-9805 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 1/2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06162221 Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC Non-Small Cell Lung Cancer, NSCLC Recruiting
NCT06445062 Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors Colorectal Cancer Recruiting
NCT06922591 Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC &… PDAC Recruiting
Phase 1
NCT06040541 Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors Non-small Cell Lung Cancer (NSCLC) Recruiting
Sponsors Running RMC-9805 Trials
Disease Areas
Get alerts when RMC-9805 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free